Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Lidocaine for Hemodynamic Response to Double-lumen Intubation
NCT05850702Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Jun 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of lidocaine in hemodynamic instability, sponsored by Renji Hospital. Status: unknown.
02
Drugs
lidocaine
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT05850702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05850702.